relative to investigating potential redundancies between the prescription drug affordability board and existing state agency programs regarding prescription drug cost data.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text History 11 Sponsors 2

Nov 16, 2023 · House

Committee Report: Inexpedient to Legislate HB172 11/08/2023 (Vote 19-0; CC)

Nov 8, 2023 · House

==CANCELLED== Executive Session: 11/15/2023 11:00 am LOB 302-304 HC 42

Oct 17, 2023 · House

==RECESSED== Executive Session: 11/08/2023 01:30 pm LOB 302-304 HC 42

Sep 6, 2023 · House

==RESCHEDULED== Subcommittee Work Session: 09/20/2023 01:15 pm LOB 302-304 HC 36

Aug 30, 2023 · House

==CANCELLED== Subcommittee Work Session: 09/06/2023 01:15 pm LOB 302-304

Mar 13, 2023 · House

Retained in Committee

Feb 23, 2023 · House

Executive Session: 03/08/2023 01:15 pm LOB 302-304

Feb 23, 2023 · House

Subcommittee Work Session: 03/08/2023 10:00 am LOB 302-304

Feb 1, 2023 · House

Subcommittee Work Session: 02/08/2023 10:45 am LOB 302-304

Jan 19, 2023 · House

Public Hearing: 01/26/2023 10:00 am LOB 302-304

Jan 3, 2023 · House

Introduced 01/04/2023 and referred to Commerce and Consumer Affairs